首页 | 本学科首页   官方微博 | 高级检索  
     

软骨组织工程种子细胞的研究进展
引用本文:何爱娟,张天宇. 软骨组织工程种子细胞的研究进展[J]. 中国眼耳鼻喉科杂志, 2001, 20(1): 3-6. DOI: 10.14166/j.issn.1671-2420.2020.01.002
作者姓名:何爱娟  张天宇
作者单位:复旦大学附属眼耳鼻喉科医院眼耳鼻整形外科 上海 200031
摘    要:肿瘤、外伤、先天畸形等导致的软骨缺损临床十分常见。目前,组织工程软骨修复技术在整形外科各领域均获得了较多进展,但种子细胞来源问题仍是限制这一技术临床应用转化的重要瓶颈。本文重点综述目前软骨组织工程技术常用的种子细胞来源,阐述各类种子细胞的生物学行为特性、研究进展及面临的挑战,为组织工程软骨的临床应用转化提供参考。

关 键 词:组织工程  种子细胞  软骨细胞  骨髓间充质干细胞  脂肪干细胞  胚胎干细胞  诱导多能干细胞  经血源子宫内膜干细胞  
收稿时间:2019-09-26

Research progress on the cell source for cartilage of tissue engineering
HE Aijuan,ZHANG Tianyu. Research progress on the cell source for cartilage of tissue engineering[J]. Chinese Journal of Ophthalmology and otorhinolaryngology, 2001, 20(1): 3-6. DOI: 10.14166/j.issn.1671-2420.2020.01.002
Authors:HE Aijuan  ZHANG Tianyu
Abstract:Cartilage lesion caused by tumor, trauma and congenital malformation is very common in clinic. Tissue engineering techniques, which can regenerate live and functional cartilage, have made great progress in various fields of plastic surgery in the past decades. However, cell source remains an important obstacle for further clinical application of tissue engineered cartilage. Here, the paper reviews the commonly used cell sources in tissue engineering of cartilage, summarizes the specific features of these candidate cells which derived from different tissues, and inspects the progress and challenges of these cells in tissue engineering cartilage. In summary, this review will provide detailed insights for the clinical application of tissue engineering cartilage.
Keywords:Tissue engineering  Cell source  Chondrocyte  Bone marrow mesenchymal stem cells  Adipose derived mesenchymal stem cells  Embryonic stem cells  Induced pluripotent stem cells  Menstrual blood-derived mesenchymal stem cells  
点击此处可从《中国眼耳鼻喉科杂志》浏览原始摘要信息
点击此处可从《中国眼耳鼻喉科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号